Abbott i-STAT High Sensitivity Troponin I Study

CompletedOBSERVATIONAL
Enrollment

3,697

Participants

Timeline

Start Date

November 2, 2022

Primary Completion Date

February 6, 2024

Study Completion Date

March 11, 2024

Conditions
Myocardial Infarction
Interventions
DIAGNOSTIC_TEST

i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity

Paired whole blood and plasma samples collected at multiple time points.

Trial Locations (28)

17033

Penn State University Hershey Medical Center, Hershey

19107

Thomas Jefferson University Hospital, Philadelphia

20037

Geroge Washington University, Washington D.C.

22903

University of Virginia, Charlottesville

27151

Wake Forest Baptist Health, Winston-Salem

29425

Medical University of South Carolina, Charleston

29505

Florence Medical Centre (MUSC Health), Florence

33606

Tampa General Hospital, Tampa

40202

Kentucky Clinical Trials Labatory, Louisville

43210

Ohio State University Medical Center, Columbus

45267

University of Cincinnati Medical Center, Cincinnati

46202

Indiana University, Indianapolis

48202

Henry Ford Health System, Detroit

55404

Hennepin Healthcare (Research Institute/Minneapolis Medical Research Foundation), Minneapolis

55906

Mayo Clinic, Rochester

63110

Washington University, St Louis

66160

University of Kansas Medical Center, Kansas City

76508

Baylor Scott and White Healthcare, Temple

77030

Baylor College of Medicine, Houston

85224

Mercy Gilbert Medical Center, Chandler

87131

University of New Mexico, Albuquerque

89012

University Medical Center of Southern Nevada, Las Vegas

94110

University of California at San Francisco, San Francisco

94305

Stanford Medical Center, Stanford

98052

Eastside Research Associates, Redmond

08103

Cooper University Hospital, Camden

11974-8167

Stony Brook University, Stony Brook

75390-8579

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

Abbott Point of Care

INDUSTRY